Enveric Biosciences, Inc. · NASDAQ:ENVB
Armistice Capital, LLC reported a 9.99% stake in Enveric Biosciences, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Armistice Capital, LLC reported a 9.99% stake in Enveric Biosciences, Inc., 405,092 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 405,092
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 9.99% | 405,092 |
| Steven Boyd | 9.99% | 405,092 |
Source
Related
- Enveric Biosciences, Inc.
- Armistice Capital, LLC
- Enveric Biosciences, Inc. shareholders
- Schedule 13G/A · Lind Global Fund III LP · Aug 14, 2026
- Schedule 13G/A · Ayrton Capital LLC · Aug 13, 2026
- Form 4 · Coveney Kevin Michael · Jun 3, 2026
- Form 4 · Tucker Joseph Edward · Jun 3, 2026
- Form 4 · Pasqualone Frank · Jun 3, 2026